Page last updated: 2024-08-22

angiotensin ii and Angiogenesis, Pathologic

angiotensin ii has been researched along with Angiogenesis, Pathologic in 95 studies

Research

Studies (95)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (4.21)	18.7374
1990's	15 (15.79)	18.2507
2000's	36 (37.89)	29.6817
2010's	35 (36.84)	24.3611
2020's	5 (5.26)	2.80

Authors

Authors	Studies
Li, C; Li, G; Liu, W; Long, X; Qiu, Z; Shen, C; Shi, B; Wang, Y; Zhang, Y; Zhao, R; Zhuang, S	1
Ge, X; Wang, SN; Wu, Y; Zhang, CQ	1
Fan, F; Liu, F; Shen, P; Tao, L; Wu, H; Zhang, H	1
Chiu, CZ; Shyu, KG; Wang, BW; Yu, YJ	1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J	1
Behl, T; Kotwani, A	1
Cooke, JP; Entman, ML; Jo, J; Kaelber, JT; Kim, E; Kim, J; Lai, L; Lee, HK; Nam, D; Reineke, EL; Suh, JH; Taffet, GE	1
Chen, Q; Deng, W; Karnik, SS; Si, W; Wang, QK; Xiao, Y; Xie, W; Xu, C	1
Guo, F; Li, XZ; Liu, HJ; Niu, P; Niu, XL; Shen, WZ; Wu, SH; Xu, YJ; Yin, XP; Zhang, TL; Zhu, JS	1
Chen, B; Hu, SJ; Mao, W; Pan, YY; Qiu, YG; Yang, JX	1
Hodi, FS; Rahma, OE	1
Chen, LY; Hu, HY; Lu, YH; Pan, LN; Qu, XL; Wang, X; Wang, ZY	1
Collado, A; Gonzalez-Navarro, H; Ortega, R; Piqueras, L; Real, JT; Sanz, MJ; Selles, F	1
Fang, C; Lin, L; Moore, A; Wen, G; Wu, S; Xiao, Q; Ye, S; Zhang, L	1
Ding, Z; Khaidakov, M; Mehta, JL; Mercanti, F; Romeo, F; Stone, A; Wang, X	1
Bai, H; Ben, J; Chen, Q; Fang, R; Li, X; Qian, L; Wang, Z; Xu, Y; Yang, Q; Zhang, H; Zhu, X	1
Cheng, XW; Hamrah, MS; Hao, CN; Hayashi, M; Hu, L; Kuzuya, M; Murohara, T; Shi, GP; Takeshita, K; Wu, H	1
Escudero, P; Ferrando, C; Furio, E; Gonzalez-Navarro, H; Juez, M; Navarro, A; Piqueras, L; Sanz, MJ	1
Chen, M; Huo, Y; Qi, J; Sun, J; Yang, P; Yi, B; Zhang, J	1
Arrieta, O; Gamboa-Domínguez, A; Guevara-Salazar, P; Hernández-Pedro, N; Pineda, B; Villanueva-Rodríguez, G; Villarreal-Garza, C; Vizcaíno, G; Wegman-Ostrosky, T	1
Alexander, IE; Angus, PW; Chin, R; Cunningham, SC; Habib, MR; Herath, CB; Mak, KY; Sharland, AF; Torresi, J	1
Beltramo, E; Carpanetto, A; Iavello, A; Mazzeo, A; Porta, M	1
Dimberg, J; Folkesson, M; Gabrielson, M; Länne, T; Matussek, A; Skogberg, J; Vorkapic, E; Wågsäter, D; Welander, M	1
Cheng, Q; Feng, Y; Li, Q; Wan, H; Zhou, J; Zhou, L	1
Fan, F; Jiang, G; Liu, Z; Lu, Y; Shen, C; Tao, L; Tian, C; Wu, H	1
Bie, P; Hansen, PBL; Jensen, BL; Johansen, SH; Lindholt, JS; Rasmussen, LM; Stubbe, J; Urbonavicius, S; Wintmo, P	1
Qin, Z	1
Boeschoten, EW; Dekker, FW; Kolesnyk, I; Krediet, RT; Noordzij, M	1
Bekaert, V; Beretz, A; Brasse, D; Etienne-Selloum, N; Schini-Kerth, VB; Schleiffer, R; Vanhoutte, PM; Walter, A	1
Cao, H; Che, J; Fei, X; Feng, Y; Han, B; Liu, J; Ma, Q; Qiu, W; Wan, H; Xiang, Y; Zhang, R	1
Batifoulier-Yiannikouris, F; Cassis, LA; Daugherty, A; Police, SB; Putnam, K; Thatcher, S	1
Asagami, T; Dalman, RL; Dua, MM; Miyama, N; Schultz, GM; Sho, E; Sho, M; Yeung, JJ	1
Aihara, Y; Fukui, H; Ikenaka, Y; Kaji, K; Kawaratani, H; Kitade, M; Namisaki, T; Noguchi, R; Shirai, Y; Tsujimoto, T; Yanase, K; Yoshii, J; Yoshiji, H	1
Kikuchi, E; Kosaka, T; Miyajima, A; Miyazaki, Y; Oya, M; Shirakawa, H; Shirotake, S; Tanaka, N	1
Sata, M	1
Burnier, M; Waeber, B; Wuerzner, G	1
Carbajo-Lozoya, J; Feng, Y; Hammes, HP; Kroll, J; Lutz, S; Wieland, T	1
Ghigo, A; Hirsch, E; Perino, A; Shah, AM; Zhang, M	1
Chen, H; Liu, L; Shi, GP; Shi, MA; Sukhova, GK; Sun, J; Zhang, J	1
Cao, X; Du, J; Guo, J; Li, H; Pan, L; Qin, Y; Shi, GP; Tang, C; Zhang, H; Zhang, Y	1
Amin, A; Badr El-Din, NK; Choi, SK; Kadowitz, P; Kevil, CG; Matrougui, K; Navar, LG; Osman-Elazeik, Y; Trebak, M	1
Chen, D; Ding, H; Li, D; Xu, T; Zhang, T; Zhang, Y; Zhu, M	1
Agrotis, A; Armani, R; Rana, I; Wilkinson-Berka, JL	1
Hayashi, I; Katada, J; Konishi, Y; Majima, M; Muramatsu, M; Tsutsumi, M	1
Menrad, A; Orzechowski, HD; Paul, M; Schirner, M; Siemeister, G; Walther, T	1
Hattori, A; Ino, K; Kajiyama, H; Kikkawa, F; Mizutani, S; Shibata, K; Tsujimoto, M; Watanabe, Y	1
Harada, M; Kitaura, Y; Komuro, I; Masaya, M; Minamino, T; Nagai, T; Sugaya, T; Terasaki, F; Toko, H; Zou, Y	1
Arrieta, O; Escobar, E; Rodríguez-Reyna, TS; Sotelo, J	1
Corrêa, FM; Cunha, FQ; de Oliveira, AM; Fukada, SY; Iyomasa, MM	1
Fujita, M; Fukamizu, A; Hayashi, I; Itoman, M; Majima, M; Yamashina, S	1
Ino, K; Kajiyama, H; Kikkawa, F; Mizutani, S; Nagasaka, T; Shibata, K; Suganuma, T	1
Wilkinson-Berka, JL	1
Hasumi, H; Ishiguro, H; Kato, S; Kubota, Y; Nagashima, Y; Nakaigawa, N; Sasaki, T; Uemura, H	1
Jin, D; Kondo, K; Miyazaki, M; Muramatsu, M; Okamoto, Y; Takai, S; Tanigawa, N	1
Dechend, R; Dudenhausen, J; Haller, H; Homuth, V; Krause, M; Luft, FC; Müller, DN; Wallukat, G	1
Cazaubon, S; Couraud, PO; Deshayes, F; Nahmias, C	1
Ushio-Fukai, M	1
Jin, D; Miyazaki, M; Muramatsu, M; Takai, S	1
Miyazaki, M; Takai, S	1
Ito, S; Sugawara, A	1
Komori, K; Kuma, S; Maehara, Y; Oki, E; Onohara, T	1
Wynn, TA	1
Alagappan, VK; Garrelds, IM; Saxena, PR; Seynhaeve, AL; Sharma, HS; ten Hagen, TL; Willems-Widyastuti, A	1
Arafat, HA; Chipitsyna, G; Gong, Q; Rizvi, A; Saa, CT; Yeo, CJ	1
Carretero, OA; Cavasin, MA; Lin, CX; Reudelhuber, TL; Shesely, EG; Xu, J; Yang, JJ; Yang, XP	1
Bagnoli, P; Cammalleri, M; Casini, G; Dal Monte, M; Martini, D	1
Agha, R; Becker, RP; Chan, LS; Chen, L; Jin, T; Li, J; Marble, DJ; Peterson, JD	1
Anandanadesan, R; Arafat, HA; Chipitsyna, G; Gong, Q; Witkiewicz, A; Yeo, CJ	1
Fraser, HM; Hack, G; Herr, D; Konrad, R; Kreienberg, R; Rodewald, M; Wulff, C	1
Abe, I; Hori, K; Saito, S; Sato, H; Suzuki, M	1
Andrade, SP; Bakhle, YS; Piper, PJ; Vieira, LB	2
Gao, XL; Li, YL; Yu, HZ	1
Bult, H; De Meyer, GR; Herman, AG; Jordaens, FH; Kockx, M; Ustünes, L; Zonnekeyn, LL	1
Haudenschild, CC; Jacobs, AK; Landau, C	1
Fan, TP; Hiley, CR; Hu, DE	1
Bock, P	1
Levy, BI	1
Beevers, DG; Headon, M; Jones, AF; Lip, GY; Lip, PL; Price, N	1
Komuro, I; Kudoh, S	1
Egashira, K; Takemoto, M	1
Sun, Y; Weber, KT	1
Jin, D; Kirimura, K; Miyazaki, M; Nishimoto, M; Sakaguchi, M; Takai, S; Yuda, A	1
Hong, KW; Kim, CD; Kim, HH; Kim, S; Kim, YK; Kwak, YK; Yoo, S	1
Andrade, SP; Machado, RD; Santos, RA	1
Achard, J; Caride, VJ; Fernandez, LA; Fournier, A; Mazouz, H; Penar, PL	1
Arrieta, O; Duarte-Rojo, A; Guevara, P; Rivera, E; Sotelo, J	1
Durie, M; Levy, BI; Silvestre, JS; Tamarat, R	1
Andrade, SP; Bakhle, YS; Hart, I; Piper, PJ	1
Hori, K; Saito, S; Suzuki, M; Tanda, S	1
Re, R	1
Fogo, A; Ichikawa, I	1
Konno, T; Maeda, H; Matsumura, Y; Miyauchi, Y; Mizutani, J; Ohtsuka, N; Yamasaki, K	1
Bache, RJ; Dai, XZ; Hautamaa, PV; Homans, DC	1
Fernandez, LA; Mead, A; Twickler, J	1

Reviews

23 review(s) available for angiotensin ii and Angiogenesis, Pathologic

Article	Year
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Potential of angiotensin II receptor blockers in the treatment of diabetic retinopathy. Life sciences, 2017, May-01, Volume: 176 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Diabetic Retinopathy; Humans; Inflammation; Neovascularization, Pathologic; Oxidative Stress; Renin-Angiotensin System	2017
The Intersection between Tumor Angiogenesis and Immune Suppression. Clinical cancer research : an official journal of the American Association for Cancer Research, 2019, 09-15, Volume: 25, Issue:18 Topics: Angiogenesis Inhibitors; Angiotensin II; Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cell Adhesion Molecules; Clinical Trials as Topic; Humans; Immunomodulation; Immunosuppression Therapy; Molecular Targeted Therapy; Neoplasms; Neovascularization, Pathologic; Research Design; Signal Transduction; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Treatment Outcome; Tumor Microenvironment; Vascular Endothelial Growth Factor A	2019
Newly developed angiotensin II-infused experimental models in vascular biology. Regulatory peptides, 2008, Oct-09, Volume: 150, Issue:1-3 Topics: Angiotensin II; Animals; Atherosclerosis; Blood Pressure; Blood Vessels; Female; Humans; Hypertension; Inflammation; Mice; Mice, Transgenic; Models, Biological; Neovascularization, Pathologic; Neovascularization, Physiologic; Postmenopause; Pre-Eclampsia; Pregnancy; Vascular Diseases	2008
[Role of chronic inflammation in the pathogenesis of atherosclerosis]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2011, Volume: 138, Issue:5 Topics: Adipokines; Adipose Tissue; Angiotensin II; Animals; Atherosclerosis; Chronic Disease; Coronary Vessels; Cytokines; Humans; Inflammation; Inflammation Mediators; Life Style; Macrophages; Neovascularization, Pathologic; Plaque, Atherosclerotic; Vascular Endothelial Growth Factor A	2011
Critical review of cancer risk associated with angiotensin receptor blocker therapy. Vascular health and risk management, 2011, Volume: 7 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Clinical Trials as Topic; Humans; Hypertension; Meta-Analysis as Topic; Neoplasms; Neovascularization, Pathologic; Obesity; Receptors, Angiotensin; Risk Factors	2011
NADPH oxidases in heart failure: poachers or gamekeepers? Antioxidants & redox signaling, 2013, Mar-20, Volume: 18, Issue:9 Topics: Aldosterone; Angiotensin II; Animals; Apoptosis; Arrhythmias, Cardiac; Enzyme Activation; Fibroblasts; Fibrosis; Heart Failure; Humans; Hydrogen Peroxide; Hypertrophy, Left Ventricular; Leukocytes; Membrane Glycoproteins; Mice; Models, Cardiovascular; Molecular Targeted Therapy; Myocytes, Cardiac; NADPH Oxidase 2; NADPH Oxidases; Neovascularization, Pathologic; Oxidative Stress; Protein Isoforms; Reactive Oxygen Species; Subcellular Fractions	2013
Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy. Clinical science (London, England : 1979), 2013, Volume: 124, Issue:10 Topics: Angiotensin II; Animals; Diabetic Retinopathy; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Infant, Newborn; Infant, Premature; Inflammation; Membrane Glycoproteins; Models, Animal; NADPH Oxidase 1; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Neovascularization, Pathologic; NF-kappa B; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System; Retina; Retinopathy of Prematurity	2013
Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer. Current vascular pharmacology, 2004, Volume: 2, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antineoplastic Agents; Cell Proliferation; Humans; Neoplasms; Neovascularization, Pathologic; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction	2004
Angiotensin and diabetic retinopathy. The international journal of biochemistry & cell biology, 2006, Volume: 38, Issue:5-6 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Animals, Genetically Modified; Diabetic Retinopathy; Humans; Hypertension; Neovascularization, Pathologic; Peptide Fragments; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System; Retina	2006
Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia. Journal of the Society for Gynecologic Investigation, 2006, Volume: 13, Issue:2 Topics: Angiotensin II; Autoantibodies; Blotting, Western; Calcium; Cell Membrane Permeability; Dimerization; Female; Humans; Immunosorbent Techniques; Neovascularization, Pathologic; Pre-Eclampsia; Pregnancy; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction	2006
[Endothelin-1, angiotensin II and cancer]. Medecine sciences : M/S, 2006, Volume: 22, Issue:4 Topics: Angiogenesis Inhibitors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antineoplastic Agents; Benzimidazoles; Biphenyl Compounds; Clinical Trials as Topic; Endothelin-1; Humans; Neoplasm Invasiveness; Neoplasms; Neovascularization, Pathologic; Receptors, Angiotensin; Receptors, Endothelin; Tetrazoles	2006
Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovascular research, 2006, Jul-15, Volume: 71, Issue:2 Topics: Angiotensin II; Animals; Atherosclerosis; Endothelial Cells; Endothelial Growth Factors; Endothelium, Vascular; Humans; NADPH Oxidases; Neovascularization, Pathologic; Neovascularization, Physiologic; Oxidation-Reduction; Signal Transduction	2006
Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models. Pharmacology & therapeutics, 2006, Volume: 112, Issue:3 Topics: Angiogenesis Inhibitors; Angiotensin II; Animals; Aortic Aneurysm; Chymases; Fibrosis; Heart Diseases; Humans; Hypertension; Mast Cells; Myocardial Infarction; Neovascularization, Pathologic; Serine Proteinase Inhibitors	2006
[Tumor suppressive effect]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 5 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Chymases; Humans; Neoplasms; Neovascularization, Pathologic; Serine Endopeptidases	2006
[Stimulatory effects of angiotensin II on angiogenesis]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 5 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Diabetic Retinopathy; Humans; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Tetrazoles; Vascular Endothelial Growth Factor A	2006
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. The Journal of clinical investigation, 2007, Volume: 117, Issue:3 Topics: Angiotensin II; Cell Proliferation; Chronic Disease; Embryonic Stem Cells; Fibroblasts; Fibrosis; Humans; Infections; Neovascularization, Pathologic; Transforming Growth Factor beta1; Wound Healing	2007
The potential role of angiotensin II in the vasculature. Journal of human hypertension, 1998, Volume: 12, Issue:5 Topics: Angiotensin II; Animals; Arteries; Humans; Hypertension; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Neovascularization, Physiologic; Rabbits; Receptors, Angiotensin; Renin-Angiotensin System; Vascular Resistance	1998
[The role of angiotensin II in the development of cardiovascular remodeling]. Nihon rinsho. Japanese journal of clinical medicine, 1999, Volume: 57, Issue:5 Topics: Angiotensin II; Animals; Endothelium, Vascular; Mice; Mice, Knockout; Neovascularization, Pathologic; Ventricular Remodeling	1999
[Vascular remodeling and angiotensin II]. Nihon rinsho. Japanese journal of clinical medicine, 1999, Volume: 57, Issue:5 Topics: Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Coronary Disease; Humans; Neovascularization, Pathologic; Recurrence	1999
Infarct scar: a dynamic tissue. Cardiovascular research, 2000, Volume: 46, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cicatrix; Collagen; Extracellular Matrix; Fibroblasts; Humans; Myocardial Infarction; Myocardium; Necrosis; Neovascularization, Pathologic; Transforming Growth Factor beta; Wound Healing	2000
Protection against ischemia: a physiological function of the renin-angiotensin system. Biochemical pharmacology, 2001, Aug-01, Volume: 62, Issue:3 Topics: Angiogenesis Inducing Agents; Angiotensin II; Animals; Humans; Ischemia; Neovascularization, Pathologic; Protective Agents; Renin-Angiotensin System	2001
Angiotensin and the regulation of cellular growth. Pathophysiologic implications for cardiovascular and noncardiovascular tissues. American journal of hypertension, 1991, Volume: 4, Issue:3 Pt 2 Topics: Angiotensin II; Animals; Cardiovascular System; Cell Division; Growth Substances; Humans; Neovascularization, Pathologic; Renin-Angiotensin System	1991

Trials

1 trial(s) available for angiotensin ii and Angiogenesis, Pathologic

Article

Year

Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.

Annales medico-psychologiques, 2021, Volume: 179, Issue:2

Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021

Other Studies

72 other study(ies) available for angiotensin ii and Angiogenesis, Pathologic

Article	Year
Exosomal MiR-29a in Cardiomyocytes Induced by Angiotensin II Regulates Cardiac Microvascular Endothelial Cell Proliferation, Migration and Angiogenesis by Targeting VEGFA. Current gene therapy, 2022, Volume: 22, Issue:4 Topics: Angiotensin II; Cell Proliferation; Culture Media, Conditioned; Exosomes; Humans; Hypertrophy; MicroRNAs; Myocytes, Cardiac; Neovascularization, Pathologic; Signal Transduction; Vascular Endothelial Growth Factor A	2022
Olmesartan Improves Hepatic Sinusoidal Remodeling in Mice with Carbon Tetrachloride-Induced Liver Fibrosis. BioMed research international, 2022, Volume: 2022 Topics: Angiotensin II; Animals; Carbon Tetrachloride; Collagen; Imidazoles; Interleukin-10; Liver Cirrhosis; Mice; Neovascularization, Pathologic; Tetrazoles; Vascular Endothelial Growth Factor A	2022
Salvianolic acid B, a new type I IRE1 kinase inhibitor, abrogates AngII-induced angiogenesis by interacting with IRE1 in its active conformation. Clinical and experimental pharmacology & physiology, 2023, Volume: 50, Issue:1 Topics: Angiotensin II; Endothelial Cells; Neovascularization, Pathologic; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases	2023
Hyperbaric oxygen activates visfatin expression and angiogenesis via angiotensin II and JNK pathway in hypoxic human coronary artery endothelial cells. Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:4 Topics: Angiotensin II; Anthracenes; Cell Movement; Cells, Cultured; Coronary Vessels; Cytokines; Endothelial Cells; Glucose; Humans; Hyperbaric Oxygenation; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; JNK Mitogen-Activated Protein Kinases; Losartan; Neovascularization, Pathologic; Nicotinamide Phosphoribosyltransferase; Oxygen; Promoter Regions, Genetic; RNA, Small Interfering; Signal Transduction	2020
Steroid receptor coactivator-2 (SRC-2) coordinates cardiomyocyte paracrine signaling to promote pressure overload-induced angiogenesis. The Journal of biological chemistry, 2017, 12-29, Volume: 292, Issue:52 Topics: Angiogenesis Inducing Agents; Angiotensin II; Animals; Heart Ventricles; Hypertrophy, Left Ventricular; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Neovascularization, Pathologic; Nuclear Receptor Coactivator 2; Paracrine Communication; Transcriptional Activation; Vascular Endothelial Growth Factor A; Ventricular Remodeling	2017
Angiotensin II increases angiogenesis by NF-κB-mediated transcriptional activation of angiogenic factor AGGF1. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2018, Volume: 32, Issue:9 Topics: Angiogenesis Inducing Agents; Angiogenic Proteins; Angiotensin II; Gene Expression Regulation; Humans; Imidazoles; Losartan; Neovascularization, Pathologic; NF-kappa B; Proto-Oncogene Mas; Pyridines; Receptor, Angiotensin, Type 1; Transcription Factor RelA; Transcriptional Activation	2018
Perfusion Computer Tomography Assessment of the Effect of Angiotensin II On Blood Flow Distribution in Rabbits with Intrarenal VX2 Tumors. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, Volume: 47, Issue:1 Topics: Angiotensin II; Animals; Hemodynamics; Kidney; Kidney Neoplasms; Male; Neovascularization, Pathologic; Perfusion; Rabbits; Tomography, X-Ray Computed; Vasoconstrictor Agents	2018
The Role of RhoA in Neovascular-Related Functions of Endothelial Progenitor Cells Induced by AngiotensinⅡ. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, Volume: 47, Issue:6 Topics: Angiotensin II; Animals; Cell Adhesion; Cell Movement; Endothelial Progenitor Cells; Male; MAP Kinase Signaling System; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; rho GTP-Binding Proteins	2018
Activation of the STAT3/microRNA-21 pathway participates in angiotensin II-induced angiogenesis. Journal of cellular physiology, 2019, Volume: 234, Issue:11 Topics: Angiogenesis Inducing Agents; Angiotensin II; Animals; Cell Movement; Cell Proliferation; Endothelial Cells; Gene Expression Regulation; Humans; Mice; MicroRNAs; Neovascularization, Pathologic; Plaque, Atherosclerotic; PTEN Phosphohydrolase; Signal Transduction; STAT3 Transcription Factor	2019
SGLT-2 (Sodium-Glucose Cotransporter 2) Inhibition Reduces Ang II (Angiotensin II)-Induced Dissecting Abdominal Aortic Aneurysm in ApoE (Apolipoprotein E) Knockout Mice. Arteriosclerosis, thrombosis, and vascular biology, 2019, Volume: 39, Issue:8 Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Aortic Dissection; Apolipoproteins E; Benzhydryl Compounds; Cells, Cultured; Chemokines; Glucosides; Humans; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Sodium-Glucose Transporter 2 Inhibitors	2019
An important role of matrix metalloproteinase-8 in angiogenesis in vitro and in vivo. Cardiovascular research, 2013, Jul-01, Volume: 99, Issue:1 Topics: Aneurysm; Angiotensin I; Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; beta Catenin; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Gene Knockdown Techniques; Human Umbilical Vein Endothelial Cells; Humans; Matrix Metalloproteinase 8; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Neovascularization, Physiologic; Plaque, Atherosclerotic; Platelet Endothelial Cell Adhesion Molecule-1; RNA Interference; Time Factors; Transfection	2013
Gene and microRNA transcriptional signatures of angiotensin II in endothelial cells. Journal of cardiovascular pharmacology, 2015, Volume: 65, Issue:2 Topics: Angiotensin II; Cell Culture Techniques; Cell Proliferation; Coronary Vessels; Endothelial Cells; Gene Expression Regulation; Humans; MicroRNAs; Neovascularization, Pathologic; Plaque, Atherosclerotic; Proto-Oncogene Proteins; Receptor, Notch4; Receptors, CXCR4; Receptors, Notch; Signal Transduction; SOXF Transcription Factors; STAT3 Transcription Factor	2015
Class A scavenger receptor deficiency augments angiotensin II-induced vascular remodeling. Biochemical pharmacology, 2014, Aug-01, Volume: 90, Issue:3 Topics: Angiotensin II; Animals; Aorta, Thoracic; Blood Vessels; Cell Proliferation; Cell Transdifferentiation; Cells, Cultured; Coculture Techniques; Crosses, Genetic; Disease Models, Animal; Hypertension; Infusions, Intravenous; Macrophages; Male; Mice; Mice, 129 Strain; Mice, Inbred ICR; Mice, Knockout; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Scavenger Receptors, Class A; Transplantation Chimera	2014
Renin inhibition reduces atherosclerotic plaque neovessel formation and regresses advanced atherosclerotic plaques. Atherosclerosis, 2014, Volume: 237, Issue:2 Topics: Amides; Angiotensin II; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Blood Pressure; Carrier Proteins; Cathepsins; Chemokine CCL2; Extracellular Matrix; Fumarates; Gene Silencing; Human Umbilical Vein Endothelial Cells; Humans; Hydralazine; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Nuclear Proteins; Plaque, Atherosclerotic; Receptor, Angiotensin, Type 1; Renin; Toll-Like Receptor 2; Treatment Outcome; Vascular Cell Adhesion Molecule-1	2014
Combined treatment with bexarotene and rosuvastatin reduces angiotensin-II-induced abdominal aortic aneurysm in apoE(-/-) mice and angiogenesis. British journal of pharmacology, 2015, Volume: 172, Issue:12 Topics: Angiogenesis Inhibitors; Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Bexarotene; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Rosuvastatin Calcium; Signal Transduction; Tetrahydronaphthalenes	2015
Heat shock protein 90 inhibition by 17-DMAG attenuates abdominal aortic aneurysm formation in mice. American journal of physiology. Heart and circulatory physiology, 2015, Apr-15, Volume: 308, Issue:8 Topics: Angiotensin II; Animals; Aortic Aneurysm; Apolipoproteins E; Benzoquinones; Cells, Cultured; Chemokine CCL2; HSP90 Heat-Shock Proteins; I-kappa B Kinase; Lactams, Macrocyclic; Male; MAP Kinase Signaling System; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Oxidative Stress	2015
Association between AT1 and AT2 angiotensin II receptor expression with cell proliferation and angiogenesis in operable breast cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015, Volume: 36, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Breast Neoplasms; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2	2015
ACE2 Therapy Using Adeno-associated Viral Vector Inhibits Liver Fibrosis in Mice. Molecular therapy : the journal of the American Society of Gene Therapy, 2015, Volume: 23, Issue:9 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cytokines; Dependovirus; Disease Models, Animal; Enzyme Activation; Gene Expression; Genetic Therapy; Genetic Vectors; Hepatic Stellate Cells; Inflammation Mediators; Injections, Intraperitoneal; Lipid Peroxidation; Liver Cirrhosis; Liver Function Tests; Male; MAP Kinase Signaling System; Methoxamine; Mice; NADPH Oxidases; Neovascularization, Pathologic; Organ Specificity; Oxidative Stress; Peptidyl-Dipeptidase A; RNA, Messenger	2015
Molecular mechanisms of extracellular vesicle-induced vessel destabilization in diabetic retinopathy. Acta diabetologica, 2015, Volume: 52, Issue:6 Topics: Angiotensin II; Cells, Cultured; Diabetic Retinopathy; Extracellular Vesicles; Humans; MicroRNAs; Neovascularization, Pathologic; Neovascularization, Physiologic; Pericytes; Platelet-Derived Growth Factor; Retinal Vessels; Signal Transduction	2015
Altered PPARγ Coactivator-1 Alpha Expression in Abdominal Aortic Aneurysm: Possible Effects on Mitochondrial Biogenesis. Journal of vascular research, 2016, Volume: 53, Issue:1-2 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Citrate (si)-Synthase; Disease Models, Animal; Gene Expression Regulation; Humans; Mice, Knockout; Mitochondria; Mitochondrial Proton-Translocating ATPases; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neovascularization, Pathologic; Organelle Biogenesis; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Voltage-Dependent Anion Channels	2016
ACE2 overexpression inhibits acquired platinum resistance-induced tumor angiogenesis in NSCLC. Oncology reports, 2016, Volume: 36, Issue:3 Topics: A549 Cells; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Organoplatinum Compounds; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Vascular Endothelial Growth Factor A	2016
Candesartan attenuates angiogenesis in hepatocellular carcinoma via downregulating AT1R/VEGF pathway. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2016, Volume: 83 Topics: Angiogenesis Inhibitors; Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Humans; Liver Neoplasms; Mice, Nude; Neovascularization, Pathologic; Receptor, Angiotensin, Type 1; Tetrazoles; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2016
The water channel AQP1 is expressed in human atherosclerotic vascular lesions and AQP1 deficiency augments angiotensin II-induced atherosclerosis in mice. Acta physiologica (Oxford, England), 2017, Volume: 220, Issue:4 Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Aquaporin 1; Coronary Artery Disease; Female; Humans; Mice; Mice, Knockout; Neovascularization, Pathologic; Vasoconstrictor Agents	2017
A positive effect of AII inhibitors on peritoneal membrane function in long-term PD patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Case-Control Studies; Cohort Studies; Creatinine; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Neovascularization, Pathologic; Peritoneal Dialysis, Continuous Ambulatory; Peritoneum; Prospective Studies; Time Factors	2009
Red wine polyphenols prevent acceleration of neovascularization by angiotensin II in the ischemic rat hindlimb. The Journal of pharmacology and experimental therapeutics, 2009, Volume: 329, Issue:2 Topics: Angiography; Angiotensin II; Animals; Blotting, Western; Disease Models, Animal; Flavonoids; Hindlimb; Ischemia; Male; Neovascularization, Pathologic; Nitric Oxide Synthase Type III; Phenols; Polyphenols; Rats; Rats, Wistar; Vascular Endothelial Growth Factor A; Wine	2009
The angiotensin-converting enzyme 2 in tumor growth and tumor-associated angiogenesis in non-small cell lung cancer. Oncology reports, 2010, Volume: 23, Issue:4 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Separation; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A	2010
Weight loss in obese C57BL/6 mice limits adventitial expansion of established angiotensin II-induced abdominal aortic aneurysms. American journal of physiology. Heart and circulatory physiology, 2010, Volume: 298, Issue:6 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Connective Tissue; Dietary Fats; Disease Models, Animal; Disease Progression; Endoglin; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Obesity; RNA, Messenger; Weight Loss	2010
Hyperglycemia limits experimental aortic aneurysm progression. Journal of vascular surgery, 2010, Volume: 52, Issue:4 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Disease Models, Animal; Disease Progression; Hypoglycemic Agents; Insulin; Macrophages; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Pancreatic Elastase; Peritonitis; Thioglycolates; Time Factors; Ultrasonography; Vascular Endothelial Growth Factor A	2010
Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats. American journal of physiology. Gastrointestinal and liver physiology, 2011, Volume: 300, Issue:6 Topics: Administration, Oral; Angiogenesis Inhibitors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzoates; Carcinoma, Hepatocellular; Cell Proliferation; Cells, Cultured; Choline Deficiency; Deferasirox; Disease Progression; Drug Therapy, Combination; Fatty Liver; Hepatic Stellate Cells; Iron Chelating Agents; Liver Cirrhosis, Experimental; Liver Neoplasms, Experimental; Losartan; Male; Neovascularization, Pathologic; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats; Rats, Inbred F344; Time Factors; Transforming Growth Factor beta1; Triazoles	2011
Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer. British journal of cancer, 2011, Oct-25, Volume: 105, Issue:9 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antipyrine; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Edaravone; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Urinary Bladder Neoplasms; Vascular Endothelial Growth Factor A	2011
Angiotensin II modulates VEGF-driven angiogenesis by opposing effects of type 1 and type 2 receptor stimulation in the microvascular endothelium. Cellular signalling, 2012, Volume: 24, Issue:6 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cattle; Cell Movement; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; GTP-Binding Protein alpha Subunits, G12-G13; Mice; Mice, Inbred C57BL; Microvessels; Neovascularization, Pathologic; Neovascularization, Physiologic; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Retina; Vascular Endothelial Growth Factor A	2012
Chemokine (C-C motif) receptor 2 mediates mast cell migration to abdominal aortic aneurysm lesions in mice. Cardiovascular research, 2012, Dec-01, Volume: 96, Issue:3 Topics: Adoptive Transfer; Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Apoptosis; Cell Proliferation; Cells, Cultured; Chemotaxis; Disease Models, Animal; Elastin; Male; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neovascularization, Pathologic; Proto-Oncogene Proteins c-kit; Receptors, CCR2	2012
Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. Cardiovascular research, 2012, Dec-01, Volume: 96, Issue:3 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Apoptosis; Cathepsin K; Cathepsins; CD3 Complex; Cells, Cultured; Collagen; Disease Models, Animal; Elastin; Inflammation; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neovascularization, Pathologic; T-Lymphocytes; Time Factors	2012
Sodium nitrite therapy rescues ischemia-induced neovascularization and blood flow recovery in hypertension. Pflugers Archiv : European journal of physiology, 2012, Volume: 464, Issue:6 Topics: Allopurinol; Angiotensin II; Animals; Arterial Pressure; Capillaries; Cyclic AMP; Cyclic GMP; Femoral Artery; Hindlimb; Hypertension; Indoles; Ischemia; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-akt; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Regional Blood Flow; Sodium Nitrite; Xanthine Dehydrogenase	2012
Luteolin inhibits angiotensin II-induced human umbilical vein endothelial cell proliferation and migration through downregulation of Src and Akt phosphorylation. Circulation journal : official journal of the Japanese Circulation Society, 2013, Volume: 77, Issue:3 Topics: Angiotensin II; Cell Movement; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Down-Regulation; Endothelium, Vascular; Humans; Luteolin; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; src-Family Kinases; Time Factors; Umbilical Veins	2013
Significance of vascular endothelial cell growth factor up-regulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas. The Journal of pharmacology and experimental therapeutics, 2002, Volume: 302, Issue:3 Topics: Angiotensin II; Animals; Cells, Cultured; Chymases; Cricetinae; Endothelial Growth Factors; Fibroblast Growth Factor 2; Fibroblasts; Granuloma; Hemoglobins; Lymphokines; Neovascularization, Pathologic; Oligonucleotides, Antisense; p-Methoxy-N-methylphenethylamine; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serine Endopeptidases; Signal Transduction; Skin; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2002
Differential regulation of in vivo angiogenesis by angiotensin II receptors. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2003, Volume: 17, Issue:14 Topics: Alginates; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Cell Line, Tumor; Enalapril; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Transgenic; Microspheres; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; Receptor, Angiotensin, Type 2; Receptors, Angiotensin	2003
Adipocyte-derived leucine aminopeptidase suppresses angiogenesis in human endometrial carcinoma via renin-angiotensin system. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Dec-15, Volume: 9, Issue:17 Topics: Adipocytes; Angiotensin II; Animals; Blotting, Western; Carcinoma; Cell Line, Tumor; Cell Movement; Cells, Cultured; Culture Media, Conditioned; DNA, Complementary; Dose-Response Relationship, Drug; Endometrial Neoplasms; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunohistochemistry; Leucyl Aminopeptidase; Mice; Mice, Nude; Neovascularization, Pathologic; Plasmids; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; Transfection; Zinc	2003
Angiotensin II type 1a receptor is involved in cell infiltration, cytokine production, and neovascularization in infarcted myocardium. Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:4 Topics: Angiotensin II; Animals; Arterioles; Capillaries; Chemotaxis, Leukocyte; Collateral Circulation; Cytokines; Enzyme Inhibitors; Granulocytes; Macrophages; Male; Mice; Mice, Knockout; Myocardial Infarction; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptor, Angiotensin, Type 1; Sarcoma 180; T-Lymphocytes; Ventricular Remodeling	2004
Mechanisms of impaired vascular response to ANG II in perivascular injured carotid arteries of ovariectomized rat. Journal of cardiovascular pharmacology, 2004, Volume: 44, Issue:3 Topics: Angiotensin II; Animals; Calcium; Carotid Artery Injuries; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Imidazoles; Implants, Experimental; Indomethacin; Muscle, Smooth, Vascular; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Ovariectomy; Photomicrography; Pyridines; Rabbits; Rats; Rats, Wistar; Silicones; Time Factors; Vasoconstriction	2004
Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth. Carcinogenesis, 2005, Volume: 26, Issue:2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Fibroblasts; Lisinopril; Mice; Mice, Inbred ICR; Mice, Knockout; Neovascularization, Pathologic; NF-kappa B; Peptidyl-Dipeptidase A; Protein Kinase C; Receptor, Angiotensin, Type 1; Sarcoma; Signal Transduction; Tetrazoles; Transcription Factor AP-1; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A	2005
Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Apr-01, Volume: 11, Issue:7 Topics: Adenocarcinoma; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antigens, CD34; Benzimidazoles; Biphenyl Compounds; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Pathologic; Ovarian Neoplasms; Peritoneum; Receptor, Angiotensin, Type 1; Tetrazoles; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2005
Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and epithelial prostate cancer cells. Molecular cancer therapeutics, 2005, Volume: 4, Issue:11 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Culture Media, Conditioned; Cytokines; Epidermal Growth Factor; Epithelial Cells; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Interleukin-6; Male; MAP Kinase Signaling System; Mice; Mice, Nude; Microcirculation; Models, Biological; Neoplasm Transplantation; Neovascularization, Pathologic; Phosphorylation; Prostatic Neoplasms; Receptors, Angiotensin; Stromal Cells; Time Factors; Tumor Necrosis Factor-alpha	2005
Expression of chymase-positive cells in gastric cancer and its correlation with the angiogenesis. Journal of surgical oncology, 2006, Jan-01, Volume: 93, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Chymases; Disease Progression; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Mast Cells; Matrix Metalloproteinase 9; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Neovascularization, Pathologic; Serine Endopeptidases; Stomach Neoplasms	2006
Angiotensin II-induced growth of vascular smooth muscle cells is associated with modulation of cell surface area and platelet-derived growth factor receptor expression. Clinical and experimental pharmacology & physiology, 2007, Volume: 34, Issue:3 Topics: Angiogenesis Inhibitors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blotting, Western; Cell Proliferation; Cell Size; Cells, Cultured; Dogs; Flow Cytometry; Hindlimb; Humans; Imidazoles; Immunohistochemistry; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Pyridines; Receptor, Platelet-Derived Growth Factor beta; Receptors, Platelet-Derived Growth Factor; Regional Blood Flow	2007
Vasoactive peptides upregulate mRNA expression and secretion of vascular endothelial growth factor in human airway smooth muscle cells. Cell biochemistry and biophysics, 2007, Volume: 47, Issue:1 Topics: Angiotensin II; Animals; Asthma; Cell Proliferation; Culture Media, Conditioned; Endothelin-1; Endothelium, Vascular; Gene Expression Regulation; Humans; Myocytes, Smooth Muscle; Neovascularization, Pathologic; Peptides; Swine; Trachea; Vascular Endothelial Growth Factor A	2007
Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma. Journal of the American College of Surgeons, 2007, Volume: 204, Issue:5 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blotting, Western; Carcinoma, Pancreatic Ductal; Chi-Square Distribution; Enzyme-Linked Immunosorbent Assay; Humans; Immunohistochemistry; Neovascularization, Pathologic; Pancreatic Neoplasms; Peptidyl-Dipeptidase A; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome; Vascular Endothelial Growth Factor A	2007
Role of cardiac overexpression of ANG II in the regulation of cardiac function and remodeling postmyocardial infarction. American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:3 Topics: Angiotensin II; Animals; Blood Pressure; Collagen; Fibrosis; Gene Expression Regulation; Heart; Heart Rate; Macrophages; Male; Mice; Mice, Transgenic; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Neovascularization, Pathologic; Ventricular Remodeling	2007
Antiangiogenic role of somatostatin receptor 2 in a model of hypoxia-induced neovascularization in the retina: results from transgenic mice. Investigative ophthalmology & visual science, 2007, Volume: 48, Issue:8 Topics: Angiotensin I; Angiotensin II; Animals; Capillaries; Disease Models, Animal; Hypoxia; Insulin-Like Growth Factor I; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Receptor, IGF Type 1; Receptor, TIE-1; Receptor, TIE-2; Receptors, Somatostatin; Retinal Diseases; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2	2007
The progression of inflammation parallels the dermal angiogenesis in a keratin 14 IL-4-transgenic model of atopic dermatitis. Microcirculation (New York, N.Y. : 1994), 2008, Volume: 15, Issue:1 Topics: Angiotensin I; Angiotensin II; Animals; Antigens, CD; Cadherins; Cells, Cultured; Dermatitis, Atopic; Dermis; Disease Models, Animal; GTP-Binding Proteins; Interferon-gamma; Interleukin-4; Interleukin-6; Keratin-14; Keratinocytes; Mice; Mice, Transgenic; Microcirculation; Neovascularization, Pathologic; Up-Regulation; Vascular Endothelial Growth Factor A	2008
Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2008, Volume: 12, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Blotting, Western; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Disease Progression; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation, Neoplastic; Genistein; Humans; Imidazoles; Immunohistochemistry; Losartan; Mitogen-Activated Protein Kinase 1; Neovascularization, Pathologic; Pancreatic Neoplasms; Protein Kinase Inhibitors; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Signal Transduction; Vascular Endothelial Growth Factor A; Vasoconstrictor Agents	2008
Potential role of Renin-Angiotensin-system for tumor angiogenesis in receptor negative breast cancer. Gynecologic oncology, 2008, Volume: 109, Issue:3 Topics: Angiopoietin-1; Angiopoietin-2; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Basic Helix-Loop-Helix Transcription Factors; Benzimidazoles; Biphenyl Compounds; Breast Neoplasms; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Neovascularization, Pathologic; Receptor, Angiotensin, Type 1; Receptors, Estrogen; Renin-Angiotensin System; Tetrazoles; Tissue Inhibitor of Metalloproteinase-1; Vascular Endothelial Growth Factor A	2008
New technique for measurement of microvascular pressure in normal and tumor vessels of rats. Invasion & metastasis, 1981, Volume: 1, Issue:4 Topics: Angiotensin II; Animals; Arteries; Blood Pressure; Blood Pressure Determination; Capillaries; Carcinoma, Hepatocellular; Liver Neoplasms; Male; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; Rats; Rats, Inbred Strains	1981
Effect of platelet activating factor (PAF) on the formation of blood vessels in subcutaneous implants in mice. Journal of lipid mediators and cell signalling, 1994, Volume: 9, Issue:2 Topics: Angiotensin II; Animals; Endothelins; Kinetics; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Platelet Activating Factor; Prostheses and Implants; Xenon Radioisotopes	1994
[Tumor microvascular bed and its reactivity to vasoactive agents: measurement of tissue blood flow and patho-morphological study]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 1994, Volume: 16, Issue:1 Topics: Angiotensin II; Animals; Liver Circulation; Liver Neoplasms, Experimental; Male; Microcirculation; Neoplasm Transplantation; Neovascularization, Pathologic; Rats	1994
Vasoconstrictor responses after neo-intima formation and endothelial removal in the rabbit carotid artery. British journal of pharmacology, 1994, Volume: 112, Issue:2 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin I; Angiotensin II; Animals; Arginine; Carotid Arteries; Endothelium, Vascular; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Nitric Oxide; Nitroarginine; omega-N-Methylarginine; Potassium Chloride; Prostaglandin Endoperoxides, Synthetic; Rabbits; Serotonin; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents	1994
Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia. American heart journal, 1995, Volume: 129, Issue:5 Topics: Analysis of Variance; Angiotensin II; Animals; Chronic Disease; Disease Models, Animal; Fibroblast Growth Factor 2; Hypertrophy, Left Ventricular; Infusion Pumps, Implantable; Male; Myocardial Ischemia; Neovascularization, Pathologic; Pericardium; Rabbits; Statistics, Nonparametric; Stimulation, Chemical	1995
Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelins-1 and -3 and angiotensin II in a rat sponge model. British journal of pharmacology, 1996, Volume: 117, Issue:3 Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Endothelins; Male; Neovascularization, Pathologic; Rats; Rats, Wistar; Receptors, Vasoactive Intestinal Peptide; Vasoactive Intestinal Peptide; Vasoconstrictor Agents; Xenon Radioisotopes	1996
The arterial length-densities under preventive angiotensin-converting-enzyme inhibiting treatment in the myocardium of spontaneously hypertensive rats. Basic research in cardiology, 1998, Volume: 93, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Capillaries; Coronary Vessels; Dose-Response Relationship, Drug; Hypertension; Myocardium; Neovascularization, Pathologic; Organ Size; Ramipril; Random Allocation; Rats; Rats, Inbred SHR; Vasoconstrictor Agents	1998
Do intraocular angiotensin II levels, plasma prothrombotic factors and endothelial dysfunction contribute to proliferative diabetic retinopathy? Acta ophthalmologica Scandinavica, 1998, Volume: 76, Issue:5 Topics: Aged; Angiotensin I; Angiotensin II; Aqueous Humor; Blood Pressure; Cell Division; Cross-Sectional Studies; Diabetic Retinopathy; Endothelium, Vascular; Female; Hemorheology; Humans; Lipoprotein(a); Male; Neovascularization, Pathologic; P-Selectin; Retinal Neovascularization; Retinal Vessels; Thrombosis	1998
Cilostazol suppresses intimal formation in dog grafted veins with reduction of angiotensin II-forming enzymes. European journal of pharmacology, 2001, Jan-12, Volume: 411, Issue:3 Topics: Angiotensin II; Animals; Blood Vessels; Chymases; Cilostazol; Dogs; In Vitro Techniques; Neovascularization, Pathologic; Peptidyl-Dipeptidase A; Serine Endopeptidases; Tetrazoles; Vasodilator Agents	2001
Antiangiogenic effect of KR31372 in rat sponge implant model. The Journal of pharmacology and experimental therapeutics, 2001, Volume: 296, Issue:3 Topics: Angiogenesis Inhibitors; Angiotensin II; Animals; Benzopyrans; Disease Models, Animal; Drug Interactions; Endothelial Growth Factors; Glyburide; Humans; Hypoglycemic Agents; Lymphokines; Models, Biological; Neovascularization, Pathologic; Prostheses and Implants; Rats; Surgical Sponges; Technetium; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2001
Mechanisms of angiotensin-(1-7)-induced inhibition of angiogenesis. American journal of physiology. Regulatory, integrative and comparative physiology, 2001, Volume: 280, Issue:4 Topics: Analysis of Variance; Angiogenesis Inhibitors; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Imidazoles; Losartan; Male; Mice; Neovascularization, Pathologic; Neovascularization, Physiologic; Peptide Fragments; Prostheses and Implants; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2	2001
AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma. British journal of cancer, 2001, Nov-02, Volume: 85, Issue:9 Topics: Angiotensin II; Animals; Antihypertensive Agents; Brain Neoplasms; Cell Division; Glioma; Losartan; Neovascularization, Pathologic; Rats; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tumor Cells, Cultured	2001
Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways. Laboratory investigation; a journal of technical methods and pathology, 2002, Volume: 82, Issue:6 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antibodies, Monoclonal; Benzimidazoles; Biphenyl Compounds; Collagen; Cyclooxygenase 2; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Endothelial Growth Factors; Female; Imidazoles; Isoenzymes; Laminin; Lymphokines; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Prostaglandin-Endoperoxide Synthases; Proteoglycans; Pyridines; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Sulfonamides; Tetrazoles; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2002
Effects of platelet activating factor (PAF) and other vasoconstrictors on a model of angiogenesis in the mouse. International journal of experimental pathology, 1992, Volume: 73, Issue:4 Topics: Angiotensin II; Animals; Endothelins; Granulation Tissue; Male; Mice; Mice, Inbred BALB C; Models, Biological; Neovascularization, Pathologic; Platelet Activating Factor; Prostheses and Implants; Regional Blood Flow; Skin; Xenon Radioisotopes	1992
Effects of tumour cells on angiogenesis and vasoconstrictor responses in sponge implants in mice. British journal of cancer, 1992, Volume: 66, Issue:5 Topics: Adenocarcinoma; Angiotensin II; Animals; Blood Vessels; Colonic Neoplasms; Endothelins; Epinephrine; Half-Life; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neovascularization, Pathologic; Platelet Activating Factor; Polyurethanes; Prostheses and Implants; Serotonin; Tumor Cells, Cultured; Vasoconstrictor Agents; Xenon Radioisotopes	1992
[Development of the angioarchitecture and microcirculatory characteristics in rat tumor]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:3 Pt 2 Topics: Angiotensin II; Animals; Blood Pressure; Liver Neoplasms, Experimental; Male; Microcirculation; Neoplasm Transplantation; Neovascularization, Pathologic; Rats; Rats, Inbred Strains; Regional Blood Flow	1990
Angiogenic action of angiotensin II is important for the glomerular growth of maturing kidneys. Kidney international. Supplement, 1991, Volume: 32 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Kidney Glomerulus; Neovascularization, Pathologic; Rats; Rats, Inbred Strains	1991
[Targeting of anticancer chemotherapy utilizing the characteristic nature of the neovasculature of solid tumors]. Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:4 Pt 2 Topics: Angiotensin II; Antineoplastic Agents; Infusions, Intra-Arterial; Iodized Oil; Molecular Weight; Neoplasms; Neovascularization, Pathologic	1986
Vasomotor activity of moderately well-developed canine coronary collateral circulation. The American journal of physiology, 1989, Volume: 256, Issue:3 Pt 2 Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Azepines; Coronary Circulation; Coronary Vessels; Dogs; Neovascularization, Pathologic; Nitroglycerin; Phenylephrine; Reference Values; Vasoconstriction; Vasopressins	1989
Neovascularization produced by angiotensin II. The Journal of laboratory and clinical medicine, 1985, Volume: 105, Issue:2 Topics: Acrylic Resins; Angiotensin II; Animals; Capillaries; Cholecystokinin; Cornea; Drug Implants; Female; Male; Neovascularization, Pathologic; Rabbits	1985